If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Sclerosing Cholangitis Medicine & Life Sciences
Biliary Liver Cirrhosis Medicine & Life Sciences
Ursodeoxycholic Acid Medicine & Life Sciences
Liver Diseases Medicine & Life Sciences
Liver Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fibrosis Medicine & Life Sciences
Cholangitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2018

Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?

Chascsa, D. M. & Lindor, K. D., Jan 1 2018, (Accepted/In press) In : Clinics in Liver Disease.

Research output: Contribution to journalArticle

Cholangitis
Antibodies
Autoimmune Hepatitis
Muscles
4 Citations

Complications, symptoms, quality of life and pregnancy in cholestatic liver disease

Zakharia, K., Tabibian, A., Lindor, K. D. & Tabibian, J. H., Mar 1 2018, In : Liver International. 38, 3, p. 399-411 13 p.

Research output: Contribution to journalReview article

Liver Diseases
Quality of Life
Pregnancy
Sclerosing Cholangitis
Cholangitis
11 Citations

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Younossi, Z. M. , Loomba, R. , Rinella, M. E. , Bugianesi, E. , Marchesini, G. , Neuschwander-Tetri, B. A. , Serfaty, L. , Negro, F. , Caldwell, S. H. , Ratziu, V. , Corey, K. E. , Friedman, S. L. , Abdelmalek, M. F. , Harrison, S. A. , Sanyal, A. J. , Lavine, J. E. , Mathurin, P. , Charlton, M. R. , Chalasani, N. P. , Anstee, Q. M. & 4 others Kowdley, K. V., George, J., Goodman, Z. D. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 361-371 11 p.

Research output: Contribution to journalReview article

Fatty Liver
Fibrosis
Therapeutics
Non-alcoholic Fatty Liver Disease
Clinical Trials
8 Citations

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Younossi, Z. M. , Loomba, R. , Anstee, Q. M. , Rinella, M. E. , Bugianesi, E. , Marchesini, G. , Neuschwander-Tetri, B. A. , Serfaty, L. , Negro, F. , Caldwell, S. H. , Ratziu, V. , Corey, K. E. , Friedman, S. L. , Abdelmalek, M. F. , Harrison, S. A. , Sanyal, A. J. , Lavine, J. E. , Mathurin, P. , Charlton, M. R. , Goodman, Z. D. & 4 others Chalasani, N. P., Kowdley, K. V., George, J. & Lindor, K., Jul 1 2018, In : Hepatology. 68, 1, p. 349-360 12 p.

Research output: Contribution to journalReview article

Fibrosis
Elasticity Imaging Techniques
Liver Cirrhosis
Liver
Non-alcoholic Fatty Liver Disease
1 Citations

Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses?

Tabibian, J. H. & Lindor, K. D., Apr 1 2018, In : Alimentary Pharmacology and Therapeutics. 47, 8, p. 1226-1227 2 p.

Research output: Contribution to journalEditorial

Liver Abscess
Proton Pump Inhibitors

Projects 2012 2019